Finn K Hansen

63PUBLICATIONS
130CO-AUTHORS
Separation technologiesMolecular targetsPharmacogenomicsOrganometallic chemistryCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (63)

|Sep 10, 2026
Rapid Two-Step Multicomponent Synthesis and Structure-degradation Relationships of Selective HDAC6 PROTAC Degraders.

|Aug 17, 2026
Novel Class I HDAC Inhibitors Sensitize Ovarian Cancer Cells for Cisplatin and Niraparib via an HDAC3-SLFN11 Axis.

|Jul 14, 2026
Targeting Histone Acetyltransferases EP300/CBP by Novel Proline-Based PROTAC Degraders.

|Apr 14, 2026
Polyfunctionalized N-Arylsulfonyl Indoles: Identification of (E)-N-Hydroxy-3-{3-[(5-(3-(piperidin-1-yl)propoxy]-1H-indol-1-yl)sulfonyl]phenyl}acrylamide (MTP150) for the Epigenetic-Based Therapy of Parkinson's Disease.

Mireia Toledano-Pinedo, Alicia Porro-Pérez, Linda Schäker-Hübner

|Apr 14, 2026
Cellular Target Engagement and Dissociation Kinetics of Class I-Selective Histone Deacetylase (HDAC) Inhibitors.

Irina Honin, Zora Novakova, Felix Feller

|Mar 19, 2026
Recommended Tool Compounds: Isoform- and Class-Specific Histone Deacetylase Inhibitors.

Linda Schäker-Hübner, Finn K Hansen

Pageof 11

Frequent Collaborators

11 joint publications

Michael Gütschow

10 joint publications

Sanil Bhatia

9 joint publications

Thomas Kurz

8 joint publications

Linda Schäker-Hübner